Eagle Pharmaceuticals, INC.
Specialty pharmaceuticals
Based in NJ
AI Overview
With $180K in lobbying spend across 4 quarterly filings, Eagle Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $80K |
| 2021 | $100K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Eagle Pharmaceuticals, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, MED, Pharmacy
Reimbursement policies for 505(b)(2) approved drugs
Issues related to pharmaceutical industry, generally
Reimbursement policies for 505(b)(2) approved drugs;
Issues related to drug pricing and Medicare and Medicaid reimbursement
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.